Abstract:Objective Alveolar macrophages (AMs) are critical for maintaining the homeostasis of pulmonary microenvironment. They process surfactants to ensure alveoli patency, and also serve as the first line of immune defense against pathogen invasion. Available studies have shown that monocyte-derived AMs continuously release pro-inflammatory cytokines and chemokines, recruiting other immune cells to the damaged area during pulmonary fibrosis. These monocyte-derived AMs maintains and amplifies inflammation, playing a negative role in pulmonary fibrosis progression. Current researches have predominantly focused on the gene expression levels of AMs in pulmonary fibrosis microenvironment, with less emphasis on the function and regulation of proteins. This study aims to investigate the differentially expressed proteins (DEPs) of AMs under normal physiological conditions and after pulmonary fibrosis, in order to gain a more comprehensive understanding of the role of AMs in the progression of pulmonary fibrosis. Methods Firstly, the construction of bleomycin-induced pulmonary fibrosis mouse models was evaluated through using measurements such as body mass, lung coefficient, lung wet-to-dry mass ratio, H&E staining and Masson staining. Subsequently, AMs from both the saline controls and the pulmonary fibrosis models (2.5x10(5) cells per sample) were collected using FACS sorting, and protein expression profiles of these cells were obtained through label-free proteomics approach. The quality of the proteomic data was assessed by comparing our saline control proteomic data with public proteomic data of physiological AMs. Thirdly, DEPs analysis between the saline controls and the bleomycin groups was carried out using R package Prostar. Functional enrichment analyses of significantly upregulated DEPs were performed using R package Clusterprofiler for GO and KEGG pathways. Finally, the STRING database was used to explore the protein-protein interaction networks related to phagocytosis regulation, inflammatory response regulation, and I-xB/NF-xB signaling pathway. The expression levels of Tlr2 and Pycard were detected respectively by FACS and western blotting. Results Compared to the saline controls, mice in the bleomycin groups exhibited a lower average body mass, extensive infiltration of inflammatory cells, and deposition of collagen in the lungs. This indicates that bleomycin successfully induced pulmonary fibrosis in mouse models. The proteomic data of AMs obtained from these models was of high quality and fulfilled the research requirements. A comprehensive analysis showed that 778 proteins were upregulated in pulmonary fibrosis groups compared with control groups. Moreover, the signal pathways enriched in up-regulated DEPs were related to the I-xB/NF-xB pathway, inflammatory response regulation, phagocytosis regulation, TGF-beta signaling, and HIF-1 pathway, indicating that AMs in pulmonary fibrosis microenvironment exerted pro-inflammatory and pro-fibrotic functions. Protein- protein interaction network analysis of the DEPs suggested that the interactions between Tlr2 and Pycard were control nodes for the pro-inflammatory phenotype of AMs, thereby contributing to pulmonary fibrosis progression. Further validation by FACS and Western blotting respectively confirmed that the expression levels of Tlr2 and Pycard in AMs were significantly increased after pulmonary fibrosis. Conclusion This study investigates the changes in the protein expression profile of AMs in the pulmonary fibrosis microenvironment. The results show that AMs notably enhanced the activity of various pathways associated with inflammation and fibrosis, suggesting that the interaction between Tlr2 and Pycard serves as a key control node for the highly pro- inflammatory behavior of AMs.

[Mrna Expression of Matrix Metalloproteinase-2 and Membrane Type Matrix Metalloproteinase in Pulmonary Fibroblasts and Macrophages of Rat Pulmonary Fibrosis Model].

[Expression of Matrix Metalloproteinase-2 in Rat Pulmonary Fibrosis].

Expression of MMP-2 and MT1-MMP in type II pneumocytes during rat pulmonary fibrosis model induced by bleomycin

[The Changes of Expression Level of Matrix Metalloprotease 9 and Its Inhibitor (TIMP-1) in Murine Pulmonary Fibrosis Model].

[Changes of Matrix Metalloproteinase 2,9 and Tissue Inhibitor of Metalloproteinase 1, 2, 3 Expression Level in Aged Rat Lung].

Expression of Tgf-Beta(1), Pdgf and Igf-1 Mrna in Lung of Bleomycin-A(5)-Induced Pulmonary Fibrosis in Rats

Macrophage-secreted TSLP and MMP9 Promote Bleomycin-Induced Pulmonary Fibrosis

Activity of Matrix Metalloproteinase in Airway Epithelial Cells of COPD Patients.

Gene Expression of MMP-1 of Pulmonary Vascular Remodeling in Rats with Pulmonary Hypertension

Particulate matter with a diameter of ≤2.5 μm induces and enhances bleomycin-induced pulmonary fibrosis by stimulating endoplasmic reticulum stress in rat.

Expression Pattern of Matrix Metalloproteinases-13 in a Rat Model of Alcoholic Liver Fibrosis.

Expression of MMP - 3 Gene in Pulmonary Vascular Remodeling Rat with Pulmonary Hypertension Induced Bymonocrotaline

Expression Change of TGF Β1 in Lungs of Rats′ Bleomycin-indued Pulminany Gibrosis Model

[Effect of Atorvastatin on MMP-9 and TIMP-1 Levels in Bronchoalveolar Lavage Fluid and Serum of Rats with Bleomycin-Induced Pulmonary Fibrosis].

MMP14high macrophages orchestrate progressive pulmonary fibrosis in SR-Ag-induced hypersensitivity pneumonitis

miR-92a-3p promotes pulmonary fibrosis progression by regulating KLF2-mediated endothelial-to-mesenchymal transition

Proteomic Analysis of Alveolar Macrophages in Pulmonary Fibrosis Microenvironment

[Expression of Major Histocompatibility Complex Class II Antigens on Lungs in Rat with Bleomycin-Induced Pulmonary Fibrosis].

Expression of Interleukin-18 in Bleomycin-Induced Pulmonary-Fibrosis in Rats

[Macrophage Apoptosis and the Levels of Interleukin-1 and Interleukin-8 in the Rats Exposed to Silica].

Study of Pulmonary Fibrosis in Mice Induced by Bleomycin A2+B2